These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8904630)
1. Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites. Lennard L; Welch J; Lilleyman JS Br J Clin Pharmacol; 1996 Oct; 42(4):525-7. PubMed ID: 8904630 [TBL] [Abstract][Full Text] [Related]
2. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations. Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957 [TBL] [Abstract][Full Text] [Related]
3. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia. Lancaster DL; Patel N; Lennard L; Lilleyman JS Cancer Chemother Pharmacol; 2002 Jul; 50(1):33-6. PubMed ID: 12111109 [TBL] [Abstract][Full Text] [Related]
4. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia. Lennard L; Cartwright CS; Wade R; Richards SM; Vora A Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716 [TBL] [Abstract][Full Text] [Related]
5. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Lennard L; Welch JC; Lilleyman JS Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462 [TBL] [Abstract][Full Text] [Related]
6. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? Lennard L; Davies HA; Lilleyman JS Br J Cancer; 1993 Jul; 68(1):186-90. PubMed ID: 8318412 [TBL] [Abstract][Full Text] [Related]
7. Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia. Lennard L; Hale JP; Lilleyman JS Br J Clin Pharmacol; 1993 Oct; 36(4):277-84. PubMed ID: 12959304 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose. Welch J; Lennard L; Morton GC; Lilleyman JS Ther Drug Monit; 1997 Aug; 19(4):382-5. PubMed ID: 9263376 [TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. Lennard L; Lewis IJ; Michelagnoli M; Lilleyman JS Med Pediatr Oncol; 1997 Oct; 29(4):252-5. PubMed ID: 9251729 [TBL] [Abstract][Full Text] [Related]
10. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1. Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328 [TBL] [Abstract][Full Text] [Related]
11. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine. Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411 [TBL] [Abstract][Full Text] [Related]
12. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828 [TBL] [Abstract][Full Text] [Related]
13. Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia. Zhou Y; Wang L; Zhai XY; Wen L; Tang F; Yang F; Liu XT; Dong L; Zhi LJ; Shi HY; Hao GX; Zheng Y; Jacqz-Aigrain E; Wang TY; Zhao W Br J Clin Pharmacol; 2020 Aug; 86(8):1519-1527. PubMed ID: 32077136 [TBL] [Abstract][Full Text] [Related]
14. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group). Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM; Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274 [TBL] [Abstract][Full Text] [Related]
15. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Harms DO; Göbel U; Spaar HJ; Graubner UB; Jorch N; Gutjahr P; Janka-Schaub GE; Blood; 2003 Oct; 102(8):2736-40. PubMed ID: 12843002 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780 [TBL] [Abstract][Full Text] [Related]
18. Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia. Chrzanowska M; Kolecki P; Duczmal-Cichocka B; Fiet J Eur J Pharm Sci; 1999 Aug; 8(4):329-34. PubMed ID: 10425383 [TBL] [Abstract][Full Text] [Related]